Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer
3.149
Zitationen
15
Autoren
2003
Jahr
Abstract
In patients with laryngeal cancer, radiotherapy with concurrent administration of cisplatin is superior to induction chemotherapy followed by radiotherapy or radiotherapy alone for laryngeal preservation and locoregional control.
Ähnliche Arbeiten
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
1993 · 15.645 Zit.
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 · 6.410 Zit.
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 · 5.074 Zit.
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
2016 · 4.943 Zit.
Head and neck squamous cell carcinoma
2020 · 3.825 Zit.
Autoren
Institutionen
- Sidney Kimmel Comprehensive Cancer Center(US)
- The University of Texas MD Anderson Cancer Center(US)
- RTOG Foundation(US)
- Moffitt Cancer Center(US)
- University of South Florida(US)
- Fox Chase Cancer Center(US)
- University of Alabama at Birmingham(US)
- VA NY Harbor Healthcare System(US)
- The Barbara Ann Karmanos Cancer Institute(US)
- Wayne State University(US)
- New York University(US)
- Columbia University Irving Medical Center(US)